Stay updated on Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications note now states that PubMed publications are automatically filled and may not pertain to the study. The page revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding/operating status banner from the Study Details page; core study information, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe new screenshot shows only minor formatting edits to the study details page and no changes to core study content (eligibility criteria, study arms, outcomes, or locations); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.SummaryDifference3%

- Check78 days agoChange Detected- Updated the page version from v3.0.2 to v3.1.0. This is a metadata/versioning change with minimal impact on substantive content.SummaryDifference0.1%

- Check85 days agoChange DetectedUpdate the citation date to reflect online-ahead-of-print status; the essential citation remains the same.SummaryDifference0.4%

Stay in the know with updates to Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.